General Information of This Drug (ID: DMZOLBI)

Drug Name
Carbamazepine   DMZOLBI
Synonyms Carbamazepine (iv, epilepsy); Carbamazepine (iv, epilepsy), Lundbeck; Carbamazepine (iv, epilepsy), Ovation Pharmaceuticals
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
5 Approved Indication(s)
Indication Name Indication ID ICD-11 Status REF
Glossopharyngeal neuralgia DISBUXSM N.A. Approved [1]
Focal epilepsy DIS4LY5L N.A. Approved [1]
Epilepsy with generalized tonic-clonic seizures DISMG0FL N.A. Approved [1]
Epilepsy DISBB28L 8A60-8A68 Approved [2]
Trigeminal neuralgia DIS31ZY6 8B82.0 Approved [1]
------------------------------------------------------------------------------------
1 NDA filed Indication(s)
Indication Name Indication ID ICD-11 Status REF
Type-1 diabetes DIS7HLUB 5A10 NDA filed [3]
------------------------------------------------------------------------------------
1 Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Gastric adenocarcinoma DISWWLTC 2B72 Phase 3 [4]
------------------------------------------------------------------------------------
1 Discontinued in Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
LennoxGastaut syndrome DISOTGO5 8A62.1 Discontinued in Phase 2 [5]
------------------------------------------------------------------------------------

References

1 Carbamazepine FDA Label
2 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5339).
3 Clinical pipeline report, company report or official report of Lundbeck.
4 ClinicalTrials.gov (NCT01128959) Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy. U.S. National Institutes of Health.
5 A Study of Sunitinib in Combination With Bevacizumab, Carboplatin, and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer (SABRE-L)